DE60312154D1 - 2-oxo-1,3,4-trihydrochinazolin derivative zur behandlung von zellproliferationskrankheiten - Google Patents

2-oxo-1,3,4-trihydrochinazolin derivative zur behandlung von zellproliferationskrankheiten

Info

Publication number
DE60312154D1
DE60312154D1 DE60312154T DE60312154T DE60312154D1 DE 60312154 D1 DE60312154 D1 DE 60312154D1 DE 60312154 T DE60312154 T DE 60312154T DE 60312154 T DE60312154 T DE 60312154T DE 60312154 D1 DE60312154 D1 DE 60312154D1
Authority
DE
Germany
Prior art keywords
treatment
diseases
trihydrochinazoline
oxo
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60312154T
Other languages
English (en)
Other versions
DE60312154T2 (de
Inventor
Qi Huang
Matthew Kaller
Thomas Nguyen
Mark H Norman
Robert Rzasa
Hui-Ling Wang
Wenge Zhong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/446,440 external-priority patent/US7119111B2/en
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of DE60312154D1 publication Critical patent/DE60312154D1/de
Application granted granted Critical
Publication of DE60312154T2 publication Critical patent/DE60312154T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE60312154T 2002-05-29 2003-05-29 2-oxo-1,3,4-trihydrochinazolin derivative zur behandlung von zellproliferationskrankheiten Expired - Lifetime DE60312154T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38426502P 2002-05-29 2002-05-29
US384265P 2002-05-29
US446440 2003-05-27
US10/446,440 US7119111B2 (en) 2002-05-29 2003-05-27 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use
PCT/US2003/016941 WO2003101985A1 (en) 2002-05-29 2003-05-29 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders

Publications (2)

Publication Number Publication Date
DE60312154D1 true DE60312154D1 (de) 2007-04-12
DE60312154T2 DE60312154T2 (de) 2007-06-21

Family

ID=29715321

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60312154T Expired - Lifetime DE60312154T2 (de) 2002-05-29 2003-05-29 2-oxo-1,3,4-trihydrochinazolin derivative zur behandlung von zellproliferationskrankheiten

Country Status (9)

Country Link
EP (1) EP1507776B1 (de)
JP (1) JP2005533039A (de)
AT (1) ATE355287T1 (de)
AU (1) AU2003273579A1 (de)
CA (1) CA2486530A1 (de)
DE (1) DE60312154T2 (de)
ES (1) ES2282646T3 (de)
MX (1) MXPA04011579A (de)
PL (1) PL373842A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20081692A1 (es) * 2007-01-24 2008-12-18 Mochida Pharm Co Ltd Nuevo derivado de heterocicliden acetamida
EP2366703B1 (de) * 2007-02-13 2014-07-30 AB Science Polymorphe Form von 2-Amino-(Nitroaryl)-Thiazol-Derivat
EP2461869B1 (de) * 2009-08-06 2013-08-21 Merck Patent GmbH Neue bicyclische harnstoffverbindungen

Also Published As

Publication number Publication date
ES2282646T3 (es) 2007-10-16
DE60312154T2 (de) 2007-06-21
CA2486530A1 (en) 2003-12-11
EP1507776B1 (de) 2007-02-28
PL373842A1 (en) 2005-09-19
EP1507776A1 (de) 2005-02-23
AU2003273579A1 (en) 2003-12-19
ATE355287T1 (de) 2006-03-15
MXPA04011579A (es) 2005-03-07
JP2005533039A (ja) 2005-11-04

Similar Documents

Publication Publication Date Title
ATE320426T1 (de) Harnstoffderivate und ihre verwendung
DE602004015810D1 (de) Substituierte isochinolinderivate und anwendungsverfahren
NO20060278L (no) Piperazinderivater og fremgangsmater for anvendelse
RS60503A (en) Substituted alkylamine derivatives and methods of use
DE602004024900D1 (de) Substituierte 2,3-dihydro-1h-isoindol-1-one derivate und anwendungsverfahren
WO2004007457A3 (en) Substituted benzylamine derivatives and methods of use
HK1116161A1 (en) Substituted amide derivatives as protein kinase inhibitors
DE60225556D1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
WO2004005279A3 (en) Substituted anthranilic amide derivatives and methods of use
EA200601239A1 (ru) Замещённые хинолиновые соединения
WO2003066630A3 (en) Quinolinone derivatives for treating cell proliferation related disorders
DE602004022633D1 (de) 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen
CY1111070T1 (el) Παραγωγα 2-αμινο-κουιναζολινης χρησιμα ως αναστολεις της β-σεκρετασης (bace)
MXPA05010883A (es) Derivados de amina ciclica y su uso en el tratamiento de trastornos inflamatorios relacionados mediados por bradiquinina.
ATE367380T1 (de) Zur behandlung von zns-erkrankungen geeignete piperazinylchinolinderivate
DE60312154D1 (de) 2-oxo-1,3,4-trihydrochinazolin derivative zur behandlung von zellproliferationskrankheiten
UA86051C2 (en) Substituted quinoline compounds
EP1619184A3 (de) Harnstoffverbindungen als Kinaseinhibitoren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition